Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Frank Michael Horling
Observed names:
F. Horling,
Frank Horling,
Frank M Horling,
Frank M. Horling
Institution:
IMC University of Applied Sciences Krems
Observed institutions:
IMC University of Applied Sciences Krems,
Baxter (Austria),
Takeda (United States),
Takeda (Austria),
University of Regensburg
OpenAlex ID:
A5110403089
Distinct characteristics of antibody responses against factor VIII in healthy individuals and in different cohorts of hemophilia A patients
2012
·
Shawn F. J. Whelan
, Christoph J. Hofbauer
, et al.
·
Blood
·
219
Prevalence of Anti-Adeno-Associated Virus Immune Responses in International Cohorts of Healthy Donors
2019
·
Anita Kruzik
, Damir Fetahagic
, et al.
·
Molecular Therapy — Methods & Clinical Development
·
194
PDF
The Mystery of Antibodies Against Polyethylene Glycol (PEG) - What do we Know?
2016
·
Christian Lubich
, Peter Allacher
, et al.
·
Pharmaceutical Research
·
180
Affinity of FVIII-specific antibodies reveals major differences between neutralizing and nonneutralizing antibodies in humans
2014
·
Christoph J. Hofbauer
, Shawn F. J. Whelan
, et al.
·
Blood
·
146
PDF
Porcine recombinant factor VIII (Obizur; OBI ‐1; BAX 801): product characteristics and preclinical profile
2015
·
D. Lillicrap
, A. Schiviz
, et al.
·
Haemophilia
·
37
Detection of Biologically Relevant Low-Titer Neutralizing Antibodies Against Adeno-Associated Virus Require Sensitive In Vitro Assays
2019
·
Anita Kruzik
, Herwig Koppensteiner
, et al.
·
Human Gene Therapy Methods
·
32
Preclinical assessment of a new recombinant ADAMTS‐13 drug product (BAX930) for the treatment of thrombotic thrombocytopenic purpura
2016
·
A. Kopić
, K. Benamara
, et al.
·
Journal of Thrombosis and Haemostasis
·
32
A formal comparison of different methods for establishing cut points to distinguish positive and negative samples in immunoassays
2011
·
Thomas Jaki
, John-Philip Lawo
, et al.
·
Journal of Pharmaceutical and Biomedical Analysis
·
28
The role of caspases in photoreceptor cell death of the retinoschisin-deficient mouse
2006
·
A. Gehrig
, A. Janssen
, et al.
·
Cytogenetic and Genome Research
·
27
Preclinical safety and efficacy of a new recombinant FIX drug product for treatment of hemophilia B
2013
·
Barbara Dietrich
, Alexandra Schiviz
, et al.
·
International Journal of Hematology
·
16
PDF
Polyethylene glycol 20 kDa-induced vacuolation does not impair phagocytic function of human monocyte-derived macrophages
2022
·
Anne Schoenbrunn
, Kerstin Juelke
, et al.
·
Frontiers in Immunology
·
11
Nonacog gamma, a novel recombinant factor IX with low factor IXa content for treatment and prophylaxis of bleeding episodes
2015
·
Peter L Turecek
, Brigitt Abbühl
, et al.
·
Expert Review of Clinical Pharmacology
·
11
A false sense of security? Can tiered approach be trusted to accurately classify immunogenicity samples?
2016
·
Thomas Jaki
, Peter Allacher
, et al.
·
Journal of Pharmaceutical and Biomedical Analysis
·
7
PDF
Immunogenicity profile of rurioctocog alfa pegol in previously treated patients with severe congenital hemophilia A
2024
·
Frank M. Horling
, Birgit M. Reipert
, et al.
·
Blood Advances
·
6
PDF
Proceedings of the 15 th European immunogenicity platform open symposium on immunogenicity of biopharmaceuticals
2025
·
Sophie Tourdot
, Karien Bloem
, et al.
·
mAbs
·
4
PDF
Evaluation of Factor VIII Polysialylation: Identification of a Longer-Acting Experimental Therapy in Mice and Monkeys
2019
·
Helmut Glantschnig
, Alexander Bauer
, et al.
·
Journal of Pharmacology and Experimental Therapeutics
·
4
PDF
A comparison of methods for classifying samples as truly specific with confirmatory immunoassays
2013
·
Thomas Jaki
, John-Philip Lawo
, et al.
·
Journal of Pharmaceutical and Biomedical Analysis
·
4
Immunogenicity of BAX 855 in Previously Treated Patients with Congenital Severe Hemophilia Α
2016
·
Frank Michael Horling
, Peter Allacher
, et al.
·
Blood
·
3
Detection of Non Inhibitory Binding Antibodies to Von Willebrand Factor Affecting the Clearance of VWF:Ag in Von Willebrand Disease
2011
·
Tobias M Suiter
, Pier Mannuccio Mannucci
, et al.
·
Blood
·
3
Die Genfamilie der Peroxiredoxine in Pflanzen: genetische Regulation und Funktion
2002
·
Frank Horling
·
PUB – Publications at Bielefeld University (Bielefeld University)
·
1
Factor IX inhibitors: Clinical and laboratory profiles of two patients with severe haemophilia B
2019
·
Surbhi Saini
, Stacy E. Croteau
, et al.
·
Haemophilia
Development of SHP648, Shire's high performing AAV8-based FIX gene therapy vector
2017
·
Frank Horling
, Falko G. Falkner
, et al.
·
Human Gene Therapy
The Effect of Inhibitory Antibodies on Acute Treatment of Bleeding Episodes with OΒΙ-1, an Antihemophilic Factor VIII (recombinant), Porcine Sequence, in Patients with Acquired Hemophilia Α
2014
·
Heinrich D. Farin
, Aaron Novack
, et al.
·
Blood
Preclinical Immunogenicity Assessment of Baxter‘s Longer-Acting FVIII Candidate BAX 855 Using Novel Preclinical Models,
2011
·
Frank M Horling
, Sandra Schwele
, et al.
·
Blood
Preclinical Immunogenicity Assessment of Baxter‘s Recombinant Factor VIIa,
2011
·
Frank M Horling
, Christine Lenk
, et al.
·
Blood
Show more works
View as search
Works count:
28
Citation count:
965
H-index:
11
I10-index:
12
Year
Topic
Type